How Are We Going To Live With Alzheimer's Disease?

被引:8
作者
Karlawish, Jason [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; DEMENTIA; DECISION; CAPACITY; HEALTH; CAREGIVERS; ABILITY;
D O I
10.1377/hlthaff.2014.0089
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Alzheimer's disease confronts us with an ethical challenge: How do we live with dignity and quality of life in the face of progressive disability and, ultimately, death? Patients' cognitive and decision-making impairments often make them unable to answer this question, and when professionals who provide services for older adults fail to recognize and accommodate these impairments, patients suffer. Patients and their caregivers need a health care system that fosters caregiving so that each will live with dignity and well-being. Another way to answer this question is to discover treatments that prevent disabling cognitive impairments, but this strategy will require expanding the Alzheimer's label to include people who do not have dementia or who are even cognitively normal. Controversies are likely to occur over how best to describe the Alzheimer's problem, measure the value of early diagnosis and treatment, and live with a brain at risk.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 50 条
  • [11] Alzheimer's Disease In African Americans: Risk Factors And Challenges For The Future
    Barnes, Lisa L.
    Bennett, David A.
    HEALTH AFFAIRS, 2014, 33 (04) : 580 - 586
  • [12] Making sense of self in Alzheimer's disease: reflective function and memory
    Simm, Louise A.
    Jamieson, Robert D.
    Ong, Ben
    Garner, Mark W. J.
    Kinsella, Glynda J.
    AGING & MENTAL HEALTH, 2017, 21 (05) : 501 - 508
  • [13] An analytic framework for conceptualisations of disease: nine structuring questions and how some conceptualisations of Alzheimer's disease can lead to 'diseasisation'
    Zeiler, Kristin
    MEDICINE HEALTH CARE AND PHILOSOPHY, 2020, 23 (04) : 677 - 693
  • [15] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [16] Brainstem morphological changes in Alzheimer's disease
    Lee, Ji Han
    Ryan, John
    Andreescu, Carmen
    Aizenstein, Howard
    Lim, Hyun Kook
    NEUROREPORT, 2015, 26 (07) : 411 - 415
  • [17] Parkinsonism in genetic and sporadic Alzheimer's disease
    Levin, Johannes
    PARKINSONISM BEYOND PARKINSON'S DISEASE, 2019, 149 : 237 - 247
  • [18] What are we trying to prevent in Alzheimer disease?
    Jessen, Frank
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2019, 21 (01) : 27 - 34
  • [19] Alzheimer's disease lymphocytes: potential for biomarkers?
    Wojda, Urszula
    BIOMARKERS IN MEDICINE, 2016, 10 (01) : 1 - 4
  • [20] Age, Alzheimer's disease, and the big picture
    Ganguli, Mary
    Rodriguez, Eric
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (10) : 1531 - 1534